147 related articles for article (PubMed ID: 7857591)
1. 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes.
Liptrot J; Holdup D; Phillipson O
J Neural Transm Gen Sect; 1994; 96(1):51-62. PubMed ID: 7857591
[TBL] [Abstract][Full Text] [Related]
2. 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol depletes catecholamines in rat brain.
Liptrot J; Holdup D; Phillipson O
J Neurochem; 1993 Dec; 61(6):2199-206. PubMed ID: 7504086
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Hirata Y; Nagatsu T
Brain Res; 1985 Jun; 337(1):193-6. PubMed ID: 2860954
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
Finnegan KT; Irwin I; Delanney LE; Langston JW
J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intra- and extrasynaptosomal monoamine oxidase-A and -B activities in the striatum and frontal cortex of two mice strains with different sensitivities to the neurotoxic actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Stenström A; Sundström E; Fowler CJ
Pharmacol Toxicol; 1989 Mar; 64(3):276-81. PubMed ID: 2786196
[TBL] [Abstract][Full Text] [Related]
6. [Effect of the atypical neuroleptics karbidin and sulpiride on the synaptosomal tyrosine hydroxylase of the corpus striatum of rats].
Meos AA; Kudrin VS; Raevskiĭ KS
Biull Eksp Biol Med; 1984 Sep; 98(9):305-8. PubMed ID: 6148973
[TBL] [Abstract][Full Text] [Related]
7. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
9. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
Azzaro AJ; King J; Kotzuk J; Schoepp DD; Frost J; Schochet S
J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
[TBL] [Abstract][Full Text] [Related]
10. Striatal synaptosomal dopamine synthesis: evidence against direct regulation by an autoreceptor mechanism.
Compton DR; Johnson KM
Eur J Pharmacol; 1985 Apr; 110(2):157-62. PubMed ID: 2859213
[TBL] [Abstract][Full Text] [Related]
11. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
13. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
Onali P; Olianas MC; Bunse B
Brain Res; 1988 Jul; 456(2):302-9. PubMed ID: 2905190
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells.
Willets JM; Lambert DG; Lunec J; Griffiths HR; Phillipson O
Environ Toxicol Pharmacol; 1996 Aug; 2(1):59-68. PubMed ID: 21781702
[TBL] [Abstract][Full Text] [Related]
15. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 synthesis-modulating receptors are present in the striatum of the guinea pig.
Johnson EA; Tsai CE; Lucci J; Harrison-Shahan Y; Azzaro AJ
Neuropharmacology; 1992 Jan; 31(1):95-101. PubMed ID: 1347405
[TBL] [Abstract][Full Text] [Related]
17. The histochemical demonstration of MPTP oxidation in the postmortem human striatum.
Nakamura S; Akiguchi I; Kimura J
Neurosci Lett; 1993 May; 154(1-2):61-4. PubMed ID: 8103202
[TBL] [Abstract][Full Text] [Related]
18. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
Hársing LG; Vizi ES
Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
[TBL] [Abstract][Full Text] [Related]
19. Enhanced hydroxyl radical generation by 2'-methyl analog of MPTP: suppression by clorgyline and deprenyl.
Chiueh CC; Huang SJ; Murphy DL
Synapse; 1992 Aug; 11(4):346-8. PubMed ID: 1323883
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
Heikkila RE; Hess A; Duvoisin RC
Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
